SCHEMBL29182995

SCHEMBL29182995

[c]1ncc(N=C(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 10/20 0.47
ESR1 P03372 9/20 0.47
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.33
MAPK14 Q16539 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPGD P15428 1/20 0.32
GFER P55789 1/20 0.32
HTR3E A5X5Y0 1/20 0.31
SLC22A2 O15244 1/20 0.31
SLC22A1 O15245 1/20 0.31
SLC22A3 O75751 1/20 0.31
HTR3B O95264 1/20 0.31
PLAU P00749 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28850122 0.75 ESR1 (0.40) ESR2ESR1MEN1KMT2AALDH1A1
SCHEMBL4450591 0.75 ESR2 (0.74) ESR2ESR1MEN1KMT2AALDH1A1
SCHEMBL15717660 0.73 ESR2 (0.71) ESR2ESR1MEN1KMT2AALDH1A1
SCHEMBL12336908 0.73 ESR2 (0.78) ESR2ESR1MEN1KMT2ALMNA
SCHEMBL28978818 0.72 ESR2 (0.43) ESR2ESR1MEN1KMT2AGAA
SCHEMBL28267335 0.71 ESR1 (0.55) ESR2ESR1MEN1KMT2AALDH1A1
SCHEMBL19783218 0.71 GRM5 (0.46) ESR2ESR1MEN1KMT2AGAA
SCHEMBL19782299 0.71 ESR1 (0.42) ESR2ESR1MEN1KMT2AGAA
SCHEMBL28183497 0.69 ESR2 (0.44) ESR2ESR1MEN1KMT2AGAA
SCHEMBL15275550 0.68 ESR2 (0.83) ESR2ESR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117794920-A N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-03-29 CN disclosed